Jun 16, 2020
New Data from Diabetes Prevention Program Outcomes Study Shows Persistent Reduction of Type 2 Diabetes Development Over 22-Year Average Follow-Up
Jun 15, 2020
Dapagliflozin May Help Reduce Onset of Type 2 Diabetes
Jun 14, 2020
Investigational, once-weekly insulin icodec showed comparable efficacy and safety to once-daily insulin glargine U100 in phase 2 trial
Jun 05, 2020
Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
Jun 04, 2020
Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes
May 28, 2020
FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release Products
May 13, 2020
Micro Labs USA Inc and Saptalis Pharmaceuticals LLC Announce Launch of Metformin Oral Solution (500 mg/5mL in two presentations 118mL and 473mL)
May 08, 2020
Higher investigational doses of Trulicity® (dulaglutide) meaningfully reduced A1C and body weight in people with type 2 diabetes
Mar 31, 2020
2020 Metformin Hydrochloride Industry Assessment - Applications, Manufacturers & Distributors, Prices, End-users and Downstream Sectors
Mar 31, 2020
Metformin Hydrochloride Market Research Report, 2020 - ResearchAndMarkets.com
Mar 11, 2020
Information Update - Certain Metformin diabetes drugs recalled due to the presence or possible presence of NDMA
Feb 05, 2020
Information Update - Apotex Inc. recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tablets
Dec 20, 2019
Cardiovascular Disease, Technology and Personalized Care Highlighted in ADA's 2020 Standards of Medical Care in Diabetes
Dec 05, 2019
Statement from Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S.
Nov 19, 2019
Oramed Provides Highlights and Data From Its Phase IIb Oral Insulin Study Investor Event
Oct 02, 2019
Upsher-Smith Laboratories Launches Tosymra(TM) (sumatriptan) Nasal Spray For The Acute Treatment Of Migraine In Adults
Sep 20, 2019
FDA approves first oral GLP-1 treatment for type 2 diabetes
Jun 26, 2019
Lilly's AWARD-11 trial studying higher investigational doses of Trulicity® (dulaglutide) demonstrated superiority in A1C reduction in people with type 2 diabetes
Jun 14, 2019
Metformin Study Shows Drug Has Promise for Women with PCOS
Jun 10, 2019
Linagliptin and Glimepiride Have Comparable Cardiovascular Safety Effects in Type 2 Diabetes at High Cardiovascular Risk